Comprehensive Insight Into Atopic Dermatitis: Understanding Disease Burden, Treatment Strategies and Emerging Therapies : Episode 5

Overcoming Barriers to Treatment in AD

April 2, 2025

By Matthew Zirwas, M.D.

Opinion

Video

An expert discusses the most common barriers clinicians face when prescribing topical therapies for atopic dermatitis (AD) and their impact on patient adherence as well as strategies dermatologists can employ to navigate insurance coverage, prior authorization and step therapy to ensure patients receive appropriate care.

EP: 1.Clinical Presentations of Atopic Dermatitis Across Patient Populations

EP: 2.Hidden Burden of AD

EP: 3.Topical Treatments in AD

EP: 4.Shared Decision-Making in AD Management

Now Viewing

EP: 5.Overcoming Barriers to Treatment in AD

EP: 6.Recent Advancements in AD Treatment

EP: 7.Integrating New AD Therapies Into Clinical Practice

EP: 8.Key Takeaways for AD Management

EP: 9.Comprehensive Insight into Atopic Dermatitis: Understanding Disease Burden, Treatment Strategies and Emerging Therapies | Written Recap

Video content above is prompted by the following:

What are the most common barriers clinicians face when prescribing topical therapies for AD, and how do they impact patient adherence?
What strategies can dermatologists employ to navigate insurance coverage, prior authorization and step therapy, and ensure patients receive appropriate care?

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!